For filings with the FSA include the annex |
|
||||
For filings with issuer exclude the annex |
X |
||||
|
|||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
|||||
|
|
||||
1. Identity of the issuer or the underlying issuer |
Cineworld Group PLC
|
||||
2 Reason for the notification (please tick the appropriate box or boxes): |
|||||
An acquisition or disposal of voting rights |
X |
||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||||
An event changing the breakdown of voting rights |
|
||||
Other (please specify): |
|
|
|||
3. Full name of person(s) subject to the |
Mawer Investment Management Ltd.
|
||||
4. Full name of shareholder(s) |
Mawer Global Small Cap Fund Manulife Global Small Cap Fund Mawer Global Equity Fund Manulife Global Equity Class
|
||||
5. Date of the transaction and date on |
November 27, 2012
|
||||
6. Date on which issuer notified: |
November 29, 2012
|
||||
7. Threshold(s) that is/are crossed or |
4% ownership
|
||||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
GB00B15FWH70 |
|
|
5,886,730
|
5,886,730
|
|
4.12%
|
|
|||||||||
|
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
n/a |
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
n/a |
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
5,886,730
|
4.12%
|
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
Mawer Global Small Cap Fund - 4,073,886 shares of Cineworld Group PLC or 2.85% Manulife Global Small Cap Fund - 1,666,844 shares of Cineworld Group PLC or 1.17% Mawer Global Equity Fund - 46,000 shares of Cineworld Group PLC or 0.03% Manulife Global Equity Class - 100,000 shares of Cineworld Group PLC or 0.07% |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
Mawer Investment Management Ltd. |
|
11. Number of voting rights proxy holder will cease |
n/a |
|
12. Date on which proxy holder will cease to hold |
n/a |
|
|
||
|
|
|
14. Contact name: |
Niels Molbak, Compliance Officer
|
|
15. Contact telephone number: |
+1 403 770 5196 |
|